Babesiosis in equines in Pakistan: a clinical report.

The research article discusses a study conducted on the tick-borne disease, Equine babesiosis, in horses in Pakistan. It explores its clinical, haematological manifestations, and the therapeutic strategies applied.

Clinical Overview

• The study was conducted on equine units in Kotley and Jehlum, parts of the Remount Veterinary and Farms Corps (RVFC) in Pakistan.
• Equine babesiosis is a haematological disease that affects horses and is transmitted via ticks. It can manifest acutely, subacutely, or chronically.
• Symptoms of the disease in horses include intermittent fever, anaemia, icterus (jaundice), and haemoglobinuria (the presence of free haemoglobin in the urine). Other notable symptoms were an increased respiratory rate, lacrimation (excessive tear production), conjunctivitis (eye inflammation), and pale mucous membranes.

Haematological Assessment

• The researchers conducted a haematological examination on the affected horses.
• Results revealed vital changes, including a decrease in the count of red blood cells and haemoglobin concentration. This explains the anaemia observed in the animals. It also indicates a reduction in the oxygen-carrying capacity of the blood, which could result in weakness and increased respiratory rates as the animals’ bodies attempt to compensate for the lack of oxygen.
• Concurrently, there was an increase in the total white blood cell count. This is a common bodily response to infection or diseases like babesiosis as white blood cells play a significant role in the immune system response.

Treatment Approach

• The equine babesiosis was successfully treated using a drug named imidocarb dipropionate.
• The prescribed dose rate was 4 mg/kg body weight, and it was administered intramuscularly four times at 72-hour intervals.
• Along with the administration of imidocarb dipropionate, supportive therapy was also provided to the ailing horses, although the exact measures included in this supportive therapy are not specified in the article abstract.
• The successful treatment of the babesiosis cases suggests that imidocarb dipropionate could be an effective therapeutic agent for dealing with equine babesiosis, although more research may be needed to validate these findings and determine the most effective treatment protocols.